This inventor holds 3 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, National Institute of Health and Medical Research. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
1 out of 898 
1 out of 1,853 
Years Active: 1999-2000
Title: Estelle Mottez: Innovator in Immunology
Introduction
Estelle Mottez is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of 3 patents, her work focuses on altered major histocompatibility complex (MHC) determinants and their applications in treating various diseases.
Latest Patents
Mottez's latest patents include groundbreaking inventions related to altered MHC class I and class II determinants. These determinants are designed to elicit immune responses when associated with antigens. The MHC class I determinant comprises polypeptide domains that are covalently linked, while the MHC class II determinant forms a specific sequence of polypeptide domains. These inventions have potential applications in the immunization and treatment of diseases such as AIDS, multiple sclerosis, lupus erythematosus, toxic shock, and snake bites.
Career Highlights
Throughout her career, Estelle Mottez has worked with esteemed institutions such as the Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding of immune responses and the development of therapeutic strategies.
Collaborations
Mottez has collaborated with notable colleagues, including Jean-Pierre Abastado and Philippe Kourilsky. These partnerships have further enriched her research and contributed to her innovative work in immunology.
Conclusion
Estelle Mottez is a trailblazer in the field of immunology, with her patents paving the way for new treatments and immunization strategies. Her contributions continue to impact the scientific community and improve health outcomes for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile